CAC
CRXT

Cowen and Company’s Clarus Therapeutics Holdings, Inc. Common Stock CRXT Stock Holding History

Cowen and Company’s Portfolio CRXT Stock Details CRXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,000
Closed -$53K – 672
2021
Q3 		$53K Buy
+10,000
New +$53K ﹤0.01% 300